Fritextsökning
Innehållstyper
-
Krönika: Collaboration across borders
-
A growing industry in Denmark: “One new life science company a week”
The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...
-
Marie Gårdmark: Do EMA and FDA talk to each other?
Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.
-
Automated opening and closing of sample vials
From technical requirements to a suitable solution
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
How to become globally competitive
Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.
-
A world-class research village
Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...
-
They’re all doing it – buying drug research
December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...
-
Opinion: Where do all the cool Swedish life science companies go?
It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...
-
New rules for diagnostic products, but who will certify them? “An extreme shortage area”
In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...
-
The perfect formula for decision-making
No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.
-
When carelessness, forgetfulness and coincidence become the researcher’s best friend
Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...
-
Drug development creates new challenges for regulators
-
Swedish life science in political focus
It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.
-
Swedish Healthtech Company 1928 Pushing Forward
The full service analytics platform is expanding the business.
-
Helena Strigård: The rise of the community
Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.
-
Globalt uttalande
Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.
-
Orexo vinner långdragen patenttvist
Amerikanska domstolen för överklagande slår fast att bolagets långa patent för Zubsolv är giltigt. Tidigare beslut som förklarade patentet ogiltigt rivs alltså upp.
-
Pharma-on-Demand
Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...
-
New diagnostic test soon ready for the market
-
Stopp för falska läkemedel
Senast om tre år, 2019, ska ett EU-gemensamt märkningssystem som garanterar säkra, receptbelagda läkemedel till patient finnas på plats. Arbetet pågår nu för fullt.
-
Product Specialist at Gradientech AB, Uppsala
-
The best wealth is Health
We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...
-
Hello Johan Billiet...
...Flanders Investment and Trade Agency, why are there so many Belgian companies represented at Biotech Forum?